Browse treatments

…hs in the U.S., with rising incidence among young adults. While CAR-T cell therapy has been successful in treating some hematologic malignancies, …

…y to remodulate tumor stroma and restore or enhance response to immunotherapy in solid tumors.Methods In this work, we leverage ARTIDIS techn…

…strate the central role we play in this therapeutic innovation. CAR-T cell therapy is a major breakthrough in the management of haematologic malig…

…gous transplants, 27 (32.1%) were allogeneic, and 2 (2.4%) were CAR-T Cell therapy.PRMPs were identified in 42.9% (n=36) of the prescriptions, wit…

…cted therapies, including autologous stem cell transplantation, CAR-T cell therapy and proteasome inhibition, as well as novel molecular targets s…

…stranded RNA sensor Retinoic Acid Inducible Gene I (RIG-I), and CAR-T cell therapy using syngeneic and human xenograft PDAC models. Tumor growth, …

…astoma cells has provided a target for immunotherapy, including CAR-T cell therapy. Recently published work using anti-GD2 CAR-T cells in relapsed…

…Background CAR-T therapy has demonstrated potent anti-tumor efficacy in treating a range…

…Background CAR-T cell therapy has shown limited efficacy in solid tumors due to factors such …

…s in treating relapsed/refractory hematologic malignancies, and CAR-T cell therapy is being avidly pursued for treatment of solid tumors. However,…

…elated deaths. There is currently only one clinical trial using CAR-T cell therapy to treat this disease and it targets ICAM-1, a protein with bro…

…Background Adoptive cellular therapy (ACT) in the form of CAR-T cell therapy has demonstrated potent clinical efficacy in hematological mali…